Detalhe da pesquisa
1.
Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals.
J Hepatol
; 2023 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716372
2.
Steroid administration for ischemic complications after radiofrequency ablation: A retrospective study.
Hepatol Res
; 53(7): 675-680, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810930
3.
Clinical utility of postablation liver tumor biopsy and possibility of gene mutation analysis.
Hepatol Res
; 53(11): 1117-1125, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486025
4.
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Gut
; 71(3): 593-604, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741640
5.
Radiofrequency Ablation of Liver Tumors in Patients on Antithrombotic Therapy: A Case-Control Analysis of over 10,000 Treatments.
J Vasc Interv Radiol
; 32(6): 869-877, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689831
6.
Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy.
J Hepatol
; 70(1): 78-86, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30336183
7.
Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
J Hepatol
; 71(3): 473-485, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31096005
8.
Ischemic complications after percutaneous radiofrequency ablation of liver tumors: Liver volume loss and recovery.
Hepatol Res
; 49(4): 453-461, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570810
9.
Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessment.
J Gastroenterol Hepatol
; 34(5): 921-928, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393960
10.
Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan.
J Hepatol
; 77(2): 569-571, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288188
11.
Limited efficacy of atezolizumab and bevacizumab for hepatocellular carcinoma previously treated with tyrosine kinase inhibitor.
Liver Int
; 41(9): 2233-2234, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288369
12.
Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients.
Hepatol Res
; 46(4): 259-68, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25788045
13.
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
J Hepatol
; 63(1): 131-40, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724366
14.
Chronological change in alpha-fetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus.
Liver Int
; 40(9): 2305-2306, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32463966
15.
Slight elevation of high-sensitivity C-reactive protein to predict recurrence and survival in patients with early stage hepatitis C-related hepatocellular carcinoma.
Hepatol Res
; 45(6): 645-55, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070147
16.
Comparison of improved prognosis between hepatitis B- and hepatitis C-related hepatocellular carcinoma.
Hepatol Res
; 45(10): E99-E107, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25559860
17.
Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography.
Hepatol Res
; 45(4): 415-22, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861870
18.
Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients.
J Gastroenterol Hepatol
; 30(2): 379-88, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25168107
19.
Spontaneous clearance of serum hepatitis C virus RNA during the clinical course of hepatocellular carcinoma in patients with chronic hepatitis C.
Hepatol Res
; 44(10): E32-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23841664
20.
Development of a transformer model for predicting the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation.
Hepatol Int
; 18(1): 131-137, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37689614